Human Immunodeficiency Virus, Restriction Factors, and Interferon

被引:102
作者
Neil, Stuart [2 ]
Bieniasz, Paul [1 ]
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Howard Hughes Med Inst, New York, NY 10016 USA
[2] Kings Coll London, Sch Med, Guys Hosp, Dept Infect Dis, London WC2R 2LS, England
基金
英国惠康基金;
关键词
MURINE LEUKEMIA-VIRUS; OLD-WORLD MONKEY; HIV-1 REVERSE TRANSCRIPTION; CYCLOPHILIN-A; RETROVIRAL RESTRICTION; TRIM5-ALPHA RESTRICTION; INHIBITS HIV-1; CELL-SURFACE; ANTIRETROVIRAL ACTIVITY; B30.2(SPRY) DOMAIN;
D O I
10.1089/jir.2009.0077
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Recent discoveries have revealed previously unappreciated complexity with which retroviruses interact with their hosts. In particular, we have become aware that many mammals, including humans, are equipped with genes encoding so-called "restriction factors," that provide considerable resistance to retroviral infection. Such antiretroviral genes are sometimes constitutively expressed, and sometimes interferon-induced. Thus they can be viewed as comprising an intrinsic immune system that provides a pre-mobilized defense against retroviral infection or, alternatively, as a specialized extension of conventional innate immunity. Antiretroviral restriction factors have evolved at an unusually rapid pace, particularly in primates, and some startling examples of evolutionary change are present in genes encoding restriction factors. Our understanding of the mechanisms by which restriction factors interfere with retroviral replication, and how their effects are avoided by certain retroviruses, is accruing, but far from complete. Such knowledge could allow for novel forms of therapeutic intervention in pathogenic retroviral infections, as well as the development of animal models of human disease.
引用
收藏
页码:569 / 580
页数:12
相关论文
共 163 条
[1]
Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: Evidence for decreased stability and aberrant processing of HIV-1 proteins [J].
Agy, MB ;
Acker, RL ;
Sherbert, CH ;
Katze, MG .
VIROLOGY, 1995, 214 (02) :379-386
[2]
The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system [J].
Argyris, Elias G. ;
Acheampong, Edward ;
Wang, Fengxiang ;
Huang, Raling ;
Chen, Keyang ;
Mukhtar, Muhammad ;
Zhang, Hui .
VIROLOGY, 2007, 367 (02) :440-451
[3]
A retrovirus restriction factor TRIM5α is transcriptionally regulated by interferons [J].
Asaoka, K ;
Ikeda, K ;
Hishinuma, T ;
Horie-Inoue, K ;
Takeda, S ;
Inoue, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (04) :1950-1956
[4]
The interferon response inhibits HIV particle production by induction of TRIM22 [J].
Barr, Stephen D. ;
Smiley, James R. ;
Bushman, Frederic D. .
PLOS PATHOGENS, 2008, 4 (02)
[5]
Barry Michele, 2006, Sci STKE, V2006, ppe21
[6]
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators [J].
Bartee, Eric ;
McCormack, Ashley ;
Fruh, Klaus .
PLOS PATHOGENS, 2006, 2 (10) :975-988
[7]
Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions [J].
Beignon, AS ;
McKenna, K ;
Skoberne, M ;
Manches, O ;
DaSilva, I ;
Kavanagh, DG ;
Larsson, M ;
Gorelick, RJ ;
Lifson, JD ;
Bhardwaj, N .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3265-3275
[8]
Cyclophilin A is required for TRIM5α-mediated resistance to HIV-1 in old world monkey cells [J].
Berthoux, L ;
Sebastian, S ;
Sokolskaja, E ;
Luban, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) :14849-14853
[9]
Restriction of lentivirus in monkeys [J].
Besnier, C ;
Takeuchi, Y ;
Towers, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11920-11925
[10]
Positional cloning of the mouse retrovirus restriction gene Fv1 [J].
Best, S ;
LeTissier, P ;
Towers, G ;
Stoye, JP .
NATURE, 1996, 382 (6594) :826-829